MUMBAI, India and NAPLES, Fla, May 13, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug… For the full story, visit the source.
BusinessMaharashtra
Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
MUMBAI, India and NAPLES, Fla, May 13, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received approval from the United States Food and Drug…
PRNewswire· 1 day ago· 2 min read
This summary is sourced from PRNewswire. Read the full article at:PRNewswire